PASG Passage Bio
- 0.807
- +0.061+8.12%
- 0.829
- +0.022+2.76%
Passage Bio News
Passage Bio | 8-K: Current report
Passage Bio | 8-K: Current report
Passage Bio | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(0.0%),Versant Ventures VI GP, L.P.(0.0%), etc.
Passage Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lynx1 Capital Management LP(13.6%),Weston Nichols(13.6%)
Passage Bio | 3: Initial statement of beneficial ownership of securities-10% Owner Lynx1 Capital Management LP
Passage Bio | 10-Q: Q2 2024 Earnings Report
Passage Bio | 8-K: Current report
Passage Bio | 8-K: Current report
Passage Bio | 8-K: Current report
Passage Bio | 8-K: Current report
Passage Bio | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.5%),Versant Ventures VI GP, L.P.(6.5%), etc.
Passage Bio | 4: Statement of changes in beneficial ownership of securities-Director Countouriotis Athena
Passage Bio | 4: Statement of changes in beneficial ownership of securities-Director GOWEN MAXINE
Passage Bio | 4: Statement of changes in beneficial ownership of securities-Director Kapadia Sandip
Passage Bio | 4: Statement of changes in beneficial ownership of securities-Director Sondhi Dolan
Passage Bio | 4: Statement of changes in beneficial ownership of securities-Director Islam Saqib
Passage Bio | 4: Statement of changes in beneficial ownership of securities-Director Porter Derrell
Passage Bio | 8-K: Current report
Passage Bio | 424B3: Prospectus
Passage Bio | 10-Q: Q1 2024 Earnings Report
Analysis
Price Target
No Data
No Data